Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group

MLA

Stone, A. M., et al. “Research Outcomes and Recommendations for the Assessment of Progression in Cancer Clinical Trials from a PhRMA Working Group.” European Journal of Cancer, vol. 47, no. 12, Aug. 2011, pp. 1763–71. EBSCOhost, https://doi.org/10.1016/j.ejca.2011.02.011.

APA

Stone, A. M., Bushnell, W., Denne, J., Sargent, D. J., Amit, O., Chen, C., Bailey-Iacona, R., Helterbrand, J., & Williams, G. (2011). Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group. European Journal of Cancer, 47(12), 1763–1771. https://doi.org/10.1016/j.ejca.2011.02.011

Chicago

Stone, A.M., W. Bushnell, J. Denne, D.J. Sargent, O. Amit, C. Chen, R. Bailey-Iacona, J. Helterbrand, and G. Williams. 2011. “Research Outcomes and Recommendations for the Assessment of Progression in Cancer Clinical Trials from a PhRMA Working Group.” European Journal of Cancer 47 (12): 1763–71. doi:10.1016/j.ejca.2011.02.011.